SCHEMBL46656

SCHEMBL46656

CNCc1cccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2654380 0.98 CYP1A2 (0.67)
Hydrochloric Acid SCHEMBL6132985 0.98 CYP1A2 (0.67)
Hydrochloric Acid SCHEMBL5755593 0.98 CYP1A2 (0.67)
SCHEMBL7982135 0.83 CYP1A2 (0.69)
SCHEMBL2861457 0.82 CYP1A2 (1.00)
SCHEMBL5361875 0.82 CYP1A2 (0.75)
Hydrochloric Acid SCHEMBL6121350 0.80 CYP1A2 (0.95)
SCHEMBL1038487 0.80 PRMT6 (1.00)
SCHEMBL1037867 0.79 CYP1A2 (0.77)
SCHEMBL29403584 0.79 ATM (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1593 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105732351-A Method for directly synthesizing aldehydes from amines 贵州大学 2016-07-06 CN claimed
EP-2228065-B1 Heterocyclo inhibitors of potassium channel function BRISTOL MYERS SQUIBB CO (US) 2012-12-26 EP claimed
US-8188101-B2 Dihydropyridopyrimidines for the treatment of AB-related pathologies ASTRAZENECA AB (SE) 2012-05-29 US claimed
CN-102272133-A Modulators of amyloid beta 2011-12-07 CN claimed
EP-2367826-A1 MODULATORS OF AMYLOID BETA. AstraZeneca AB (SE) 2011-09-28 EP claimed
EP-1831206-B1 N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY OSI PHARM INC (US) 2011-08-24 EP claimed
JP-4669479-B2 2011-04-13 JP claimed
US-20100256143-A1 PHARMACEUTICAL COMPOUNDS BAKER STEWART JAMES 2010-10-07 US claimed
EP-1699778-B1 (4-PHENYLPIPERAZIN-1-YL)ACYLPIPERIDINE DERIVATIVES, PREPARATION THEREOF AND APPLICATION OF SAME IN THERAPEUTICS SANOFI AVENTIS (FR) 2010-07-14 EP claimed
US-20100130495-A1 COMPOUNDS 563 ASTRAZENECA AB (SE) 2010-05-27 US claimed
US-6479492-B1 TREATMENT OF INFLAMMATORY DISEASES IN A MAMMALIAN PATIENT ELAN PHARMACEUTICALS, INC. 2002-11-12 US claimed
US-20020103170-A1 Oxazinoquinolones useful for the treatment of viral infections PHARMACIA & UPJOHN COMPANY 2002-08-01 US claimed
WO-2002012166-A2 TRIAMINE DERIVATIVE MELANOCORTIN RECEPTOR LIGANDS AND METHODS OF USING SAME LION BIOSCIENCE AG (DE) 2002-02-14 WO claimed
WO-2002004462-A1 OXAZINOQUINOLONES USEFUL FOR THE TREATMENT OF VIRAL INFECTIONS PHARMACIA & UPJOHN COMPANY (US) 2002-01-17 WO claimed
WO-2001085714-A1 AMINO SUBSTITUTED DIBENZOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS MEDIATED BY THE NP Y5 RECEPTOR ASTRAZENECA AB (SE) 2001-11-15 WO claimed
EP-1104763-A1 NAPHTHYRIDINE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2001-06-06 EP claimed
EP-0502119-B1 LIPOSPHERES FOR CONTROLLED DELIVERY OF SUBSTANCES SCIOS NOVA INC (US) 1996-01-31 EP claimed
US-5221535-A Sustained release formulations of insect repellent NOVA PHARMACEUTICAL CORPORATION (US) 1993-06-22 US claimed
EP-0502119-A1 LIPOSPHERES FOR CONTROLLED DELIVERY OF SUBSTANCES. NOVA PHARM CORP (US) 1992-09-09 EP claimed
WO-1991007171-A1 LIPOSPHERES FOR CONTROLLED DELIVERY OF SUBSTANCES NOVA PHARMACEUTICAL CORPORATION (US) 1991-05-30 WO claimed